Loading...

Danaher Corporation

DHR•NYSE
Healthcare
Medical - Diagnostics & Research
$207.73
$-4.07(-1.92%)

Danaher Corporation (DHR) Stock Overview

Explore Danaher Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 74.7/100

Key Financials

Market Cap148.8B
P/E Ratio43.64
EPS (TTM)$4.70
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Week$189.37
1 Month$172.07
3 Months$206.39
1 Year Target$263.58

DHR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Danaher Corporation (DHR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $263.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 43.64 and a market capitalization of 148.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.77%
5-Day Change
-7.50%
1-Month Change
-11.90%
3-Month Change
-23.08%
6-Month Change
-32.14%
Year-to-Date (YTD) Change
-21.32%
1-Year Change
-26.46%
3-Year Change
-29.93%
5-Year Change
39.59%
All-Time (Max) Change
30252.02%

Contact Information

https://www.danaher.com
202 828 0850
2200 Pennsylvania Avenue, NW, Washington, DC, 20037-1701

Company Facts

61,000 Employees
IPO DateDec 29, 1978
CountryUS
Actively Trading

Frequently Asked Questions

;